Larissa A Meyer, MD, MPH
Disclosures: Grant or research support-AstraZeneca|Stocks or stock options, excluding diversified mutual funds-Johnson and Johnson|Stocks or stock options, excluding diversified mutual funds-Invitae|Stocks or stock options, excluding diversified mutual funds-Denali|Stocks or stock options, excluding diversified mutual funds-Crispr Therapeutics|Stocks or stock options, excluding diversified mutual funds-Bristol-Myers Squibb|Membership on Advisory Committees or Review Panels, Board Membership, etc.-GlaxoSmithKline (Relationship has ended) - 07/15/2022
No Bio Available.